Application of FcRn Binding Assays to Guide mAb Development-Reference-Cited by-同舟云学术

Application of FcRn Binding Assays to Guide mAb Development

Published:2014-07-14 Issue:11 Volume:42 Page:1867-1872
ISSN:0090-9556
Container-title:Drug Metabolism and Disposition
language:en
Short-container-title:Drug Metab Dispos

Author:

Datta-Mannan Amita,Wroblewski Victor J.

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmaceutical Science,Pharmacology

Reference43 articles.

1. Physiochemical and Biochemical Factors Influencing the Pharmacokinetics of Antibody Therapeutics

2. Therapeutic antibodies for autoimmunity and inflammation

3. Increasing Serum Half-life and Extending Cholesterol Lowering in Vivo by Engineering Antibody with pH-sensitive Binding to PCSK9

4. Beta 2-microglobulin-deficient mice are protected from hypergammaglobulinemia and have defective antibody responses because of increased IgG catabolism;Christianson;J Immunol,1997

5. Increasing the Affinity of a Human IgG1 for the Neonatal Fc Receptor: Biological Consequences

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinetic modeling of the plasma pharmacokinetic profiles of ADAMTS13 fragment and its Fc-fusion counterpart in mice;Frontiers in Pharmacology;2024-03-25

2. Monoclonal antibodies in breast cancer: A critical appraisal;Critical Reviews in Oncology/Hematology;2023-03

3. Intravital Microscopy Reveals Unforeseen Biodistribution Within the Liver and Kidney Mechanistically Connected to the Clearance of a Bifunctional Antibody;Drug Metabolism and Disposition;2022-12-02

4. Physiologically Based Modeling to Predict Monoclonal Antibody Pharmacokinetics in Humans from in vitro Physiochemical Properties;mAbs;2022-05-01

5. Pharmacokinetic Developability and Disposition Profiles of Bispecific Antibodies: A Case Study with Two Molecules;Antibodies;2021-12-28